| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 9e-05 |